ella(ulipristal acetate) 30mg tablet
ELLA Rx
Generic Name and Formulations:
Ulipristal acetate 30mg; tab.
Company:
Afaxys Pharmaceuticals
Indications for ELLA:
Prevention of pregnancy following unprotected intercourse or known or suspected contraceptive failure. Not for use as regular contraceptive.
Adult:
Take 1 tab as soon as possible within 120hrs (5 days) after unprotected intercourse or contraceptive failure. May repeat dose if vomiting occurs within 3hrs.
Children:
Premenarchal: not applicable.
Contraindications:
Known/suspected pregnancy.
Warnings/Precautions:
Not for termination of an existing pregnancy. Exclude pregnancy before prescribing. Rule out ectopic pregnancy if lower abdominal pain occurs. Rule out pregnancy if subsequent menses delayed by >1 week. Does not protect against HIV or other STDs. Repeat use within same menstrual cycle: not recommended. Nursing mothers.
Pharmacological Class:
Progesterone agonist/antagonist.
Interactions:
Avoid concomitant CYP3A4 inducers (eg, barbiturates, bosentan, carbamazepine, felbamate, griseofulvin, oxcarbazepine, phenytoin, rifampin, topiramate, St. John's wort). Potentiated by CYP3A4 inhibitors (eg, ketoconazole, itraconazole). May antagonize regular hormonal contraceptives; use barrier contraception for remainder of menstrual cycle and resume oral contraceptives ≥5 days after dose.
Adverse Reactions:
Headache, abdominal pain, nausea, dysmenorrhea, fatigue, dizziness; menstrual cycle changes.
How Supplied:
Tab—1 |
